Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Oct 14;25(10):6319-6337.
doi: 10.1021/acs.biomac.4c00835. Epub 2024 Sep 16.

Stimuli-Responsive Substrates to Control the Immunomodulatory Potential of Stromal Cells

Affiliations
Review

Stimuli-Responsive Substrates to Control the Immunomodulatory Potential of Stromal Cells

David A Castilla-Casadiego et al. Biomacromolecules. .

Abstract

Mesenchymal stromal cells (MSCs) have broad immunomodulatory properties that range from regulation, proliferation, differentiation, and immune cell activation to secreting bioactive molecules that inhibit inflammation and regulate immune response. These properties provide MSCs with high therapeutic potency that has been shown to be relevant to tissue engineering and regenerative medicine. Hence, researchers have explored diverse strategies to control the immunomodulatory potential of stromal cells using polymeric substrates or scaffolds. These substrates alter the immunomodulatory response of MSCs, especially through biophysical cues such as matrix mechanical properties. To leverage these cell-matrix interactions as a strategy for priming MSCs, emerging studies have explored the use of stimuli-responsive substrates to enhance the therapeutic value of stromal cells. This review highlights how stimuli-responsive materials, including chemo-responsive, microenvironment-responsive, magneto-responsive, mechano-responsive, and photo-responsive substrates, have specifically been used to promote the immunomodulatory potential of stromal cells by controlling their secretory activity.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing financial interest.

References

    1. Müller L; Tunger A; Wobus M; von Bonin M; Towers R; Bornhäuser M; Dazzi F; Wehner R; Schmitz M Immunomodulatory Properties of Mesenchymal Stromal Cells: An Update. Front Cell Dev Biol. 2021, 9, 637725. - PMC - PubMed
    1. Gao F; Chiu SM; Motan DAL; Zhang Z; Chen L; Ji HL; Tse HF; Fu QL; Lian Q Mesenchymal Stem Cells and Immunomodulation: Current Status and Future Prospects. Cell Death & Disease 2016, 7 (1), No. e2062. - PMC - PubMed
    1. Ankrum JA; Ong JF; Karp JM Mesenchymal Stem Cells: Immune Evasive, Not Immune Privileged. Nat. Biotechnol. 2014, 32 (3), 252–260. - PMC - PubMed
    1. Liu Q; Zheng H; Chen X; Peng Y; Huang W; Li X; Li G; Xia W; Sun Q; Xiang AP Human Mesenchymal Stromal Cells Enhance the Immunomodulatory Function of CD8+CD28− Regulatory T Cells. Cell Mol. Immunol 2015, 12 (6), 708–718. - PMC - PubMed
    1. Shi Y; Wang Y; Li Q; Liu K; Hou J; Shao C; Wang Y Immunoregulatory Mechanisms of Mesenchymal Stem and Stromal Cells in Inflammatory Diseases. Nature Reviews Nephrology 2018, 14 (8), 493–507. - PubMed

Publication types

LinkOut - more resources